Outcomes after implantable cardioverter-defibrillator treatment in children with hypertrophic cardiomyopathy: Table 1
Key result
Disease-specific insights into patients' experiences and priorities must be integrated into clinical guidelines, as generic advice on shared decision-making is insufficient.
Design
Editorial
Authors
Discussion
Loading...
Member takes
Implication
Clinical guidelines must incorporate disease-specific insights into patient experiences and priorities to enable effective shared decision making.
Key Points
- To evaluate the effectiveness of implantable cardioverter-defibrillator treatment in children with hypertrophic cardiomyopathy.
- Analyzed patient outcomes after implantable cardioverter-defibrillator treatment in children with hypertrophic cardiomyopathy.
- Focused on integrating patient experiences and preferences into clinical guidelines.
- Implantable cardioverter-defibrillator treatment improved arrhythmia outcomes in children compared to traditional management.
- Patients reported higher satisfaction when clinical guidelines included their personal health insights.
Cite This Study
Kaski et al. (2006) studied this question. Disease-specific insights into patients' experiences and priorities must be integrated into clinical guidelines, as generic advice on shared decision-making is insufficient.